GL1X · GenesisL1 explorer

Research workbench

Orally active 2-amino thienopyrimidine inhibitors of the HSP90 chaperone

Analyse Orally active 2-amino thienopyrimidine inhibitors of the HSP90 chaperone in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WI2
Type
protein
Length
416 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Heat shock protein HSP 90-alpha
UniProt
P07900
Ligands
ZZ3
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHeat shock protein HSP 90-alphaprotein20844% helix, 24% strandP07900

Ligands and binding sites

  • ZZ3 · 4-methyl-6-(methylsulfanyl)-1,3,5-triazin-2-amine · ligand · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12940.630.8032ZZ3
21810.590.8225ZZ3

Compared structures

  • 2WI2 · Orally Active 2-Amino Thienopyrimidine Inhibitors of the Hsp90 Chaperone · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.